NUR ZAHIRAH BINTI MEOR MOHAMAD ALI UNIT KOKURIKULUM
The Medical DNA Detector (MedDNA) is an innovative portable diagnostic device designed to revolutionize molecular testing by providing rapid, accurate and affordable DNA-based detection outside conventional laboratory settings. Current diagnostic methods often involve high costs, long waiting periods and dependence on centralized laboratory facilities, limiting accessibility for patients in rural or under-resourced areas. This results in delayed treatment, advanced disease progression and increased healthcare expenditure. The main objective of MedDNA is to deliver a compact, user-friendly and efficient diagnostic solution capable of identifying genetic disorders such as thalassemia and cystic fibrosis, infectious diseases including HIV and hepatitis and even early-stage cancers within minutes. The target users include healthcare professionals, community clinics and diagnostic laboratories seeking fast and reliable results for improved patient management. MedDNA utilizes a combination of advanced biotechnologies such as CRISPR-Cas systems for nucleic acid detection, microfluidic sample processing, mini PCR modules for DNA amplification and graphene-based nanochip biosensors for precise signal detection. The device processes small blood samples and displays results within 15 to 30 minutes through an integrated LCD interface. From a commercial perspective, MedDNA demonstrates strong market potential with an estimated retail price of RM1,500 to RM2,000 per unit and disposable test cartridges costing between RM20 and RM40, offering a highly competitive alternative to traditional laboratory tests. The innovation contributes to the healthcare industry by enhancing diagnostic accessibility, supporting early disease detection and reducing hospital burdens. It also benefits society through improved public health outcomes and aligns with sustainable development goals that promote innovation and equitable healthcare access. Overall, MedDNA represents a transformative advancement that bridges biotechnology, nanoscience and digital health for the future of precision medicine.